Admission Date:  [**2194-12-30**]              Discharge Date:   [**2195-1-6**]  Date of Birth:  [**2124-10-8**]             Sex:   M  Service: MEDICINE  Allergies: No Known Allergies / Adverse Drug Reactions  Attending:[**First Name3 (LF) 3984**] Chief Complaint: Left shoulder pain Dyspnea on exertion  Major Surgical or Invasive Procedure: Bronchoscopy  History of Present Illness: Mr. [**Known lastname 4509**] is a 70M with hx of metastatic prostate cancer with known metastases to the lung and thoracic/lumbar spine with progression on multiple lines of prior therapy who presents with left shoulder pain.
He developed worsening pain in this region and an obvious deformity over his clavicle.
He is short of breath with telephone conversations and minimal movement.
With respect to his end-stage prostate cancer, the patient recently discontinued treatment with XL184 ([**Hospital1 4601**] clinical trial) on [**2194-12-11**] due to extreme fatigue.
He has remained transfusion dependent, receiving 2U PRBCs on a weekly basis over the past two weeks.
Most recently, patient received 2 units of PRBCs for HCT 21.9 on [**12-23**].
Recent oncology notes document a recent improvement in energy level since discontinuing XL184, attributed to participation with physical therapy, transfusions, and an increased dose of steroids (dexamethasone 4 mg [**Hospital1 **]).
He was given vancomycin X 1 and piperacillin/tazobactam X 1.
Denies chest pain, chest pressure, palpitations, or weakness.
PSH: prostatectomy, L cataract, L knee arthroscopy .
Onc hx:(as per recent d/c summary) - [**2187-11-23**] prostate biopsy which demonstrated with prostate cancer demonstrated in [**8-22**] cores, [**Doctor Last Name **] 3+3 - [**2188-1-7**] prostatectomy was performed with surgical pathology revealing a [**Doctor Last Name **] pattern of 3+4 was noted, one left pelvic lymph node was removed, without malignancy identified.
- [**2191-8-3**] VATS resection of nodule - pathology from demonstrated metastatic adenocarcinoma, consistent with metastasis from a prostatic origin based on immunostains that demonstrated tumor being positive for PSA and cytokeratin cocktail.
They were negative for cytokeratin 7, 20, PSAP and TTF-1 with satisfactory controls.
- [**2191-8-11**] started Lupron therapy - [**2194-6-5**] Casodex added to Lupron - [**9-19**] rising PSA, started on KHAD trial - [**2193-9-3**] ketoconazole stopped - [**2193-10-31**] started DES - [**2193-12-11**] bronchoscopy  with endobronchial ultrasound-guided transbronchial needle aspiration of station 7 and 4R and biopsies of mucosal irregularity at carina and proximal left main.
- [**2193-12-11**] positive for malignant cells, immunoreactive for PSA, PSAP and keratin AE1/AE3, CAM 5.2 - [**Date range (3) 59642**] Taxotere x 3 cycles - [**Date range (3) 59643**] cabazitaxel x 3 cycles - [**Date range (3) 59644**] abiraterone - [**2194-8-21**] cycle 4 Taxotere - [**2194-9-25**] clinical trial of [**Doctor Last Name 360**] XL-184 ([**Hospital1 4601**] protocol 09-432).
General: Alert, oriented, no acute distress, speaks in [**2-13**] word phrases HEENT: Sclera anicteric, MMM, oropharynx clear Neck: supple, JVP 8 cm Lungs: Clear to auscultation bilaterally, no wheezes, rales, rhonchi CV: Regular rate and rhythm, normal S1 + S2, no m/r/g Abdomen: soft, non-tender, non-distended, bowel sounds present, no rebound tenderness or guarding, no organomegaly Ext: left arm in sling, bony deformity over left clavicle, neurovascularly intact distally, 1+ LE edema b/l  Discharge exam: expired  Pertinent Results: Admission Labs: [**2194-12-29**] 11:00PM BLOOD WBC-7.1 RBC-2.06* Hgb-6.0* Hct-17.8* MCV-87 MCH-29.2 MCHC-33.7 RDW-20.8* Plt Ct-20* [**2194-12-29**] 11:00PM BLOOD Neuts-57 Bands-3 Lymphs-25 Monos-8 Eos-1 Baso-0 Atyps-0 Metas-3* Myelos-3* NRBC-18* [**2194-12-29**] 11:00PM BLOOD PT-12.6* PTT-23.5* INR(PT)-1.2* [**2194-12-30**] 08:19AM BLOOD Fibrino-391# [**2194-12-29**] 11:00PM BLOOD Glucose-116* UreaN-40* Creat-0.9 Na-138 K-4.5 Cl-103 HCO3-23 AnGap-17 [**2194-12-30**] 08:19AM BLOOD LD(LDH)-2456* [**2194-12-29**] 11:00PM BLOOD proBNP-1001* [**2194-12-30**] 07:43PM BLOOD Calcium-8.0* Phos-3.8 Mg-2.1 [**2194-12-30**] 08:19AM BLOOD Hapto-<5* [**2194-12-30**] 12:42AM BLOOD Lactate-2.5* [**2194-12-30**] 07:05AM BLOOD Lactate-0.9 [**2194-12-30**] 07:05AM BLOOD Type-ART pO2-64* pCO2-32* pH-7.49* calTCO2-25 Base XS-1 Intubat-NOT INTUBA Comment-NASAL [**Last Name (un) 154**]  Microbiology: Viral swab Bronch culture blood culture  Imaging: CXR [**2194-12-29**]: 1.
Patient was treated for potential infectious pneumonia.
Patient was placed on high dose steroids which did not improve respiratory status.
Patient was placed on morphine drip to help with dyspnea.
Pain control with oxycontin + oxycodone home dose.
Decision was made by patient, Mr. [**Known firstname 449**] [**Known lastname 4509**] to change his code status from FULL to DNR/DNI with request for no heroic efforts to be made in the setting of cardio/pulmonary distress.
When patient's breathing became too severe, he was started on morphine drip and made comfort measures only through discussion with his wife, HCP.
# Hypothyroidism: Continued home dose levothyroxine until patient made comfort measures only.
Medications on Admission: DEXAMETHASONE - 4 mg Tablet [**Hospital1 **] (8 am, noon) LEUPROLIDE - 7.5 mg Syringe - monthly LEVOTHYROXINE - 100 mcg daily LORAZEPAM - 0.5-1 mg q8H prn insomnia, anxiety OMEPRAZOLE - 40 mg daily OXYCODONE - 5-10 mg q3hr prn pain OXYCONTIN - 10 mg q 8hr ASPIRIN - 81 mg daily IBUPROFEN   Discharge Medications: expired  Discharge Disposition: Expired  Discharge Diagnosis: expired  Discharge Condition: expired  Discharge Instructions: expired  Followup Instructions: expired                               [**First Name8 (NamePattern2) **] [**Last Name (NamePattern1) 2437**] MD [**MD Number(1) 2438**]
